Top Tech Companies in Boston, MA (4,460)

Strong Revenue Growth: Revenue increased year over year in 2025 and accelerated further in early 2026, with adjusted operating income also rising. This points to broad-based top-line momentum beyond a single period.

Strong Market Position & Advantage: The company is characterized as the world’s largest asset manager with record-high assets under management and leading ETF scale. This scale advantage underpins continued client inflows and platform reach.

Diversified Revenue Streams: Growth is coming from multiple engines, including iShares ETFs, active strategies, private markets, and technology services such as Aladdin, alongside newer digital-asset offerings. This breadth reduces reliance on any single product line.

Strong Revenue Growth: Net revenue rose at double‑digit rates in 2025 and continued to increase at a similar pace in early 2026, supported by higher gross dollar volume, cross‑border activity, and switched transactions. The multi‑quarter trend indicates consistent top‑line momentum rather than a one‑off spike.

Profitability: Operating income outpaced revenue growth in 2025, expanding margins, while net income and EPS also advanced strongly. This points to operating leverage as volumes and higher‑yield cross‑border flows scale.

Diversified Revenue Streams: Value‑added services and solutions grew markedly faster than the core network, with security, digital authentication, analytics, and consulting cited as key contributors. This mix shift broadens growth beyond card payment fees and supports resilience.

Strong Revenue Growth: Recent results show accelerating top-line momentum, with FY2025 up 28% and Q2 2026 revenue up 36% year over year after 32% in Q1. Management also raised 2026 revenue guidance to $4.45B–$4.47B, indicating confidence in continued expansion.

Healthy Cash Flow: Cash generation is substantial, including Q2 2026 operating cash flow of $316M and free cash flow of $279M with about a 25% free-cash-flow margin. The company also reported roughly $5.0B in cash, cash equivalents and marketable securities as of June 30, 2026.

Customer Loyalty & Retention: Expansion within the installed base is a key driver, with about 75% of the 2025 revenue increase coming from existing customers and rising multi‑product adoption. Larger accounts are also expanding, as $100K+ ARR customers grew roughly 23% year over year to ~4,720 in Q2 2026.

Strong Revenue Growth: Revenue increased 19% in 2025 and accelerated in 2026 with 22% year-over-year growth in Q1 and 27% in Q2, while first-half 2026 revenue rose 25% year over year. Management raised full-year 2026 guidance to $94–96M, implying roughly 22–24% growth.

Customer Loyalty & Retention: Net Dollar Retention reached 117% in Q1 2026, indicating expanding spend from existing accounts after churn. Core genomics customers rose to 537 as of March 31, 2026, with record new customer additions in 2025.

Market Expansion: Geographic momentum is evident with Q1 2026 analysis volume up 28% in the U.S. and 31% in APAC, and EMEA revenue up 30%. Platform usage set records (e.g., 108,000 analyses in Q1 and 115,000 in Q2), with liquid biopsy volumes growing sharply.

Profitability: Operating income has risen materially alongside growth, with the latest quarter reporting meaningful GAAP and adjusted operating profits and expanding margins. This indicates the business is scaling while improving earnings quality.

Resilient & Sustainable Growth: Gross profit is expanding at a strong, accelerating pace, with both Cash App and Square contributing and management raising full‑year outlooks. Longer‑term disclosures also highlight multi‑year compounding in gross profit per user across ecosystems.

Cost & Operational Efficiency: A leaner organizational structure and disciplined spending have driven record adjusted operating margins and improved operating leverage. Efficiency gains appear to be a second engine alongside revenue drivers.

Strong Revenue Growth: Revenue has scaled materially, with ARR approaching the $400M mark and leadership targeting expansion toward $1B, alongside earlier signals such as 42% YoY ARR growth and very high renewal/net expansion. Feedback suggests recent indications of ~$300–350M revenue and expanding customer/end‑user coverage reinforce continued momentum.

Investor Backing & Capital Strength: A majority investment by Vista Equity Partners at an approximately $3B valuation signals strong capital support and confidence in the company’s scaling prospects. Feedback suggests this backing, including associated financing, enables continued product and geographic expansion.

Strong Market Position & Advantage: Repeated recognition as a Leader in Gartner’s DEX Magic Quadrant (2024–2026) and Forrester’s EUEM Wave points to sustained category leadership. Large‑scale enterprise adoption (e.g., 1,500+ customers and 25M+ employees served) further entrenches competitive positioning.

Strong Revenue Growth: Revenue is reported to have expanded dramatically over a recent three-year period, earning recognition on a leading high-growth list. Feedback suggests this reflects substantial commercial traction rather than growth based solely on financing.

Strong Market Position & Advantage: Customer adoption spans 500+ MedTech companies, including deep penetration among the largest enterprises (e.g., 16 of the top 20). Feedback suggests this breadth and upmarket presence signal durable positioning within its niche.

Investor Backing & Capital Strength: Capital raised has surpassed $160M with a recent late-stage round and a valuation near the unicorn threshold. Feedback suggests this funding base supports continued product expansion, AI initiatives, and go-to-market scale.

Profitability: Adjusted EBITDA and margins expanded, with Q2 2026 EBITDA up 30% year over year and margin improving to 37%, alongside higher net income. This pattern indicates operating leverage as earnings outpace the top line.

Strong Revenue Growth: Revenue rose 7% in 2025 and accelerated to 11% year over year in Q2 2026, with multiple sequential quarters showing improving trends. The recent trajectory points to faster growth rather than a flat profile.

Healthy Cash Flow: Free cash flow is guided to grow at more than 30% for 2026 and was later raised to the high-40% range, while Q2 2026 generated $57.4M in operating cash. Debt reduction in 1H 2026, including repayment of $205M in convertibles, further supports balance-sheet strength.

Profitability: Net income rose to $6.79B in 2025 from $4.38B in 2024. The combined ratio improved materially (e.g., S&P-adjusted 89.7% in 2025 and high-80s in early 2026), indicating stronger underwriting performance.

Investor Backing & Capital Strength: Shareholders’ equity increased from about $22.2B in 2022 to $39.9B at year-end 2025 and exceeded $44B by mid-2026. External ratings actions (AM Best A affirmation in Sept 2025; S&P upgrade to A+ in July 2026) underscore improved capitalization.

Resilient & Sustainable Growth: S&P describes deliberate portfolio reshaping and expects 2–3% annual premium growth during 2026–2028. Management emphasizes disciplined, selective expansion following underwriting improvements, prioritizing durable returns over sheer volume.

Market Expansion: ASI has broadened beyond commercial aviation into defense and critical infrastructure, adding a DIU sustainment tool, a National Grid collaboration, and a Joby partnership alongside a major FAA program rolling out from the Washington, D.C. region. Company materials describe a scope spanning aviation, defense, logistics, energy and more, with locations in Boston, Washington, D.C., and Gdańsk.

Strong Market Position & Advantage: A 12-year, $875M FAA selection for FMDS and SMART—now in operational deployment around Washington, D.C.—signals meaningful competitive strength at national scale. Available reporting indicates ASI prevailed in a field that included larger incumbents, underscoring differentiation.

Strong Hiring & Retention: Signals include a “rapidly expanding team,” added offices, and recent defense-oriented roles (e.g., a Data Lead in Colorado Springs), with external coverage citing 165+ employees and plans to grow beyond 250 to deliver major programs. Active postings across technical and federal roles further reflect continued team build-out.

Market Expansion: District reach has expanded from 1,000+ around the 2021 acquisition to 1,900+ by early 2026, with coverage across 50+ states and over half of U.S. EL students. This indicates broadening geographic penetration and customer footprint.

Product Line Growth: The offering has evolved from EL program management and instructional tools into a unified ELD platform that now includes benchmark assessment via the 2026 Ellevation Benchmark launch. This broader scope points to increased relevance and potential expansion within existing districts.

Strong Market Position & Advantage: The company is frequently described as a leading, specialized provider in its EL/MLL niche, serving 1,900+ districts and 2.5M+ learners. Such penetration suggests a defensible position within its targeted category.

Strong Revenue Growth: Recent filings and earnings updates indicate sustained double-digit increases across annual and quarterly revenue, with momentum continuing into 2026. Guidance was raised during the year, reinforcing ongoing top-line expansion across core verticals.

Profitability: Results point to improving earnings quality, including a shift to positive net income on an annual basis and expanding adjusted EBITDA margins. Management also signaled further margin gains in 2026.

Customer Loyalty & Retention: Disclosures highlight a growing client base alongside net dollar-based retention that indicates expansion within existing customers. Wins across education, travel, healthcare, and B2B suggest durable relationships that support recurring growth.

Strong Revenue Growth: Revenue is rising at double-digit rates across recent periods, and management has increased full-year guidance, underscoring continued momentum. Growth is visible in both recent quarters and the prior year, indicating sustained top-line expansion.

Diversified Revenue Streams: Both Diagnostics and Data & Applications are expanding, with data-licensing/Insights activity increasing alongside clinical testing volumes. This mix reduces reliance on a single line of business and supports multiple growth vectors.

Strategic Partnerships: Collaborations with major biopharmaceutical companies and broader rollouts of platforms such as Next signal expanding commercial reach. Announced initiatives like a large whole‑genome dataset and work with firms including Merck reinforce external demand for the platform.

Strong Revenue Growth: Recent results show revenue rising from $1.62B in FY2023 to $2.17B in FY2024, $2.67B in FY2025, and about $3.35B in FY2026, with Q4 FY2026 up 25% year over year. This trajectory, alongside mid‑20% ARR growth, indicates continued expansion rather than a stall.

Healthy Cash Flow: Cash generation is growing, with free cash flow rising to about $779M in FY2026 and a free‑cash‑flow margin near 23%. Non‑GAAP operating metrics, including an ~80% gross margin, underscore operating leverage.

Strong Market Position & Advantage: Industry evaluations list the company as a Leader in the 2026 Gartner Magic Quadrants for both SSE and SASE, with five consecutive years of SSE leadership. Expanding large‑enterprise adoption and thousands of customers support a durable position in its core zero trust/SSE markets.

Strong Revenue Growth: Revenue growth is underscored by consecutive placements on Deloitte Technology Fast 500 and the Inc. 5000, indicating multi-year expansion measured through 2025. Recognition spans overlapping earlier periods and a more recent measurement window, signaling sustained momentum rather than a one-off spike.

Market Expansion: Geographic reach widened with the opening of a UK office to support customers in the UK and EMEA following the international-payments launch and 2025 rebrand. This move complements a global customer base reported in prior updates.

Product Line Growth: The platform broadened with launches such as International Payments and Touchless Invoice Processing, with further plans cited for e-invoicing, analytics, and faster payment processing. Rising invoice-processing volumes over 2023–2025 further reflect growing adoption.

Strong Hiring & Retention: Hiring and headcount are expanding, with disclosures of 15,000+ global employees, thousands of new hires, and third‑party estimates indicating continued workforce growth. Available evidence also points to active internal mobility and a recent increase in active job postings.

Market Expansion: Geographic and client footprints are broadening, with 40+ offices and 1,700+ customers across 170+ countries alongside concrete investments in new and expanded locations such as Hyderabad and Kingston. These moves indicate scaling delivery capacity in major capability centers and new regions.

Innovation-Driven Growth: The offering mix is shifting toward AI, data, technology, and platforms, including proprietary solutions and product capabilities. Strategic moves such as Salesforce-focused acquisitions and collaborations, plus a Tulip solution partnership, extend capabilities beyond traditional consulting.

Resilient & Sustainable Growth: Revenue and ARR continued to rise, with ARR surpassing $300M by 2025 and revenue increasing in 2024. Feedback suggests growth has moderated from earlier hypergrowth into a steadier, efficiency‑focused trajectory while the customer base expanded to 4,500+.

Product Line Growth: Snyk Code reached $100M in ARR and newer offerings such as DAST and AI‑focused products (e.g., Evo) showed strong momentum. These developments indicate the platform is extending beyond its original core into additional security categories.

Market Expansion: Enterprise adoption intensified, with that segment driving a large share of new additions and AI security opening fresh routes to demand. Customer counts grew materially from 2024 into 2025, signaling broader market reach.

Strong Market Position & Advantage: Ekotrope is positioned as the most widely used HERS rating software in the U.S., supporting roughly 1 in 4 new homes and serving 7,000+ builders with 400,000+ homes per year. Penetration spans hundreds of HERS rating companies and more than 40 utility new‑construction programs.

Investor Backing & Capital Strength: An $11M financing in October 2025, bringing tracked cumulative funding to about $15.9M, underscores continued capital support for expansion. Multiple independent profiles indicate the company has raised additional capital over time rather than a single one‑off event.

Product Line Growth: The company has expanded beyond its core RATER tool into Market Intelligence data products and solutions for utilities, builders, manufacturers, and lenders. Release history shows major version updates (e.g., Version 5.0 in 2025 with additional releases in 2026), indicating an active roadmap.

Strong Revenue Growth: Reported results show revenue rising from $3.67B (2023) to $4.77B (2024) to $6.05B (2025), with early 2026 revenue and guidance pointing to further gains. Q1 2026 continued to grow year over year, alongside expanding sportsbook handle and average monthly payers.

Profitability: Reported results show Adjusted EBITDA improving from $181M (2024) to $620M (2025) and a shift to positive GAAP net income in 2025. Guidance indicates substantial Adjusted EBITDA for 2026.

Product Line Growth: Company disclosures describe rising iGaming revenue in 2025 and the launch of new offerings like Predictions and a consolidated “super app.” These additions broaden the business beyond traditional sportsbook and DFS.

Strong Revenue Growth: ARR increased from $177M in 2024 to $218M in 2025, with reported ARR roughly doubling since 2021. Platform activity also expanded as GMV rose from $11.2B to about $14.6–$15B over the same period.

Profitability: The group was profitable throughout 2025, following earlier profitability in the core Platform business. This progression indicates improving operating leverage alongside continued expansion.

Diversified Revenue Streams: Newer products are contributing incremental revenue, with Mirakl Connect generating about $11.7M ARR in under a year and Mirakl Ads seeing a sharp rise in ad spend in 2025. Customer additions (45 global enterprises in 2025) and launches across marketplace and dropship broaden the commercial base.